Charles River Laboratories International, Inc. (CRL)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS1598641074
334.76 USD
-1.78% today Updated 13 Nov 2026 16:26
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Charles River Laboratories International, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
17 Feb 2027
in 96 days · 08:00 · estimate 3.31
Last results
3.09 vs 2.98 estimated
04 Nov 2026 · Beat +3.6%
Beat the estimate
12 of 12
0 missed · 0 in line · 12 beats in a row
Average surprise
+8.5%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 17 Feb 2027 08:00 | 3.31 | — | — | Upcoming |
| 04 Nov 2026 07:00 | 2.98 | 3.09 | +3.6% | Beat |
| 05 Aug 2026 07:00 | 2.74 | 3.02 | +10.3% | Beat |
| 07 May 2026 07:00 | 1.95 | 2.06 | +5.4% | Beat |
| 18 Feb 2026 07:00 | 2.35 | 2.39 | +1.9% | Beat |
| 05 Nov 2025 07:00 | 2.34 | 2.43 | +3.9% | Beat |
| 06 Aug 2025 07:00 | 2.55 | 3.12 | +22.5% | Beat |
| 07 May 2025 07:00 | 2.07 | 2.34 | +12.8% | Beat |
| 19 Feb 2025 07:00 | 2.53 | 2.66 | +5.2% | Beat |
| 06 Nov 2024 07:00 | 2.42 | 2.59 | +6.9% | Beat |
| 07 Aug 2024 07:00 | 2.39 | 2.80 | +17.0% | Beat |
| 09 May 2024 07:00 | 2.06 | 2.27 | +10.0% | Beat |
| 14 Feb 2024 07:00 | 2.40 | 2.46 | +2.4% | Beat |
| 08 Nov 2023 07:00 | 2.37 | 2.72 | +14.9% | Beat |
| 09 Aug 2023 07:00 | 2.64 | 2.69 | +2.0% | Beat |
| 11 May 2023 07:00 | 2.59 | 2.78 | +7.4% | Beat |
| 22 Feb 2023 07:00 | 2.75 | 2.98 | +8.6% | Beat |
| 02 Nov 2022 07:00 | 2.50 | 2.63 | +5.4% | Beat |
| 03 Aug 2022 07:00 | 2.74 | 2.77 | +1.3% | Beat |
| 04 May 2022 07:00 | 2.72 | 2.75 | +1.3% | Beat |
| 16 Feb 2022 07:00 | 2.43 | 2.49 | +2.4% | Beat |
| 03 Nov 2021 07:00 | 2.58 | 2.70 | +4.8% | Beat |
| 04 Aug 2021 07:00 | 2.38 | 2.61 | +9.6% | Beat |
| 04 May 2021 07:00 | 2.19 | 2.53 | +15.4% | Beat |
| 17 Feb 2021 07:00 | 2.11 | 2.39 | +13.5% | Beat |
| 29 Oct 2020 07:00 | 1.80 | 2.33 | +29.6% | Beat |
| 05 Aug 2020 07:00 | 1.28 | 1.58 | +23.8% | Beat |
| 07 May 2020 07:00 | 1.46 | 1.84 | +25.7% | Beat |
| 11 Feb 2020 07:00 | 1.83 | 2.01 | +9.6% | Beat |
| 06 Nov 2019 07:00 | 1.64 | 1.69 | +3.0% | Beat |
| 31 Jul 2019 07:00 | 1.55 | 1.63 | +5.0% | Beat |
| 07 May 2019 07:00 | 1.39 | 1.40 | +0.7% | In line |
| 13 Feb 2019 07:00 | 1.40 | 1.49 | +6.2% | Beat |
| 07 Nov 2018 07:00 | 1.38 | 1.53 | +10.6% | Beat |
| 08 Aug 2018 07:00 | 1.46 | 1.62 | +10.9% | Beat |
| 10 May 2018 07:00 | 1.26 | 1.38 | +9.4% | Beat |
| 13 Feb 2018 07:00 | 1.25 | 1.40 | +11.7% | Beat |
| 09 Nov 2017 07:00 | 1.22 | 1.30 | +6.4% | Beat |
| 09 Aug 2017 07:00 | 1.22 | 1.29 | +6.0% | Beat |
| 10 May 2017 07:00 | 1.14 | 1.29 | +13.6% | Beat |
| 14 Feb 2017 06:00 | 1.11 | 1.21 | +9.1% | Beat |
| 02 Nov 2016 07:00 | 1.13 | 1.18 | +4.2% | Beat |
| 03 Aug 2016 07:00 | 1.10 | 1.20 | +8.9% | Beat |
| 04 May 2016 07:00 | 0.90 | 0.98 | +8.8% | Beat |
| 10 Feb 2016 07:00 | 0.94 | 1.00 | +6.6% | Beat |
| 04 Nov 2015 07:00 | 0.94 | 1.03 | +9.3% | Beat |
| 30 Jul 2015 07:00 | 0.97 | 0.96 | -0.9% | In line |
| 29 Apr 2015 16:00 | 0.82 | 0.79 | -3.9% | Miss |
| 10 Feb 2015 16:00 | 0.71 | 0.81 | +13.5% | Beat |
| 29 Oct 2014 16:00 | 0.80 | 0.86 | +7.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 4B | -0.9% | -144.3M | -3.6% | -2.91 | -1,555.0% | 518.5M |
| 2024 | 4B | -1.9% | 10.3M | 0.3% | 0.20 | -97.8% | 501.6M |
| 2023 | 4.1B | +3.9% | 474.6M | 11.5% | 9.22 | -2.7% | 365.4M |
| 2022 | 4B | — | 486.2M | 12.2% | 9.48 | — | 294.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 343.44 | 358.77 | 326.29 | 334.76 | -0.82% | 3,655,705 | |
| 02 Nov 2026 – 06 Nov 2026 | 368.42 | 369.61 | 311.68 | 337.52 | -6.09% | 7,670,900 | |
| 26 Oct 2026 – 30 Oct 2026 | 347.59 | 379.63 | 345.89 | 359.41 | +4.07% | 6,024,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 303.33 | 351.21 | 297.56 | 345.37 | +15.07% | 8,009,100 | |
| 12 Oct 2026 – 16 Oct 2026 | 301.80 | 310.53 | 295.15 | 300.15 | -0.54% | 3,841,400 | |
| 05 Oct 2026 – 09 Oct 2026 | 292.05 | 333.30 | 288.43 | 301.79 | +4.00% | 6,327,600 | |
| 28 Sep 2026 – 02 Oct 2026 | 289.13 | 298.98 | 284.61 | 290.19 | -0.90% | 3,622,000 | |
| 21 Sep 2026 – 25 Sep 2026 | 279.37 | 298.40 | 275.88 | 292.84 | +5.32% | 6,113,300 | |
| 14 Sep 2026 – 18 Sep 2026 | 278.27 | 285.58 | 267.27 | 278.06 | -0.07% | 5,674,600 | |
| 08 Sep 2026 – 11 Sep 2026 | 285.60 | 285.94 | 272.06 | 278.26 | -3.55% | 3,050,600 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- GMRS vs. CRL: Which Stock Should Value Investors Buy Now? (opens in a new tab) Zacks · 12 Nov 2026 15:40
- Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability (opens in a new tab) 12 Nov 2026 13:00
- Charles River Laboratories Recent $470 Million Deal an 'Attractive Strategic Addition,' Analyst Says (opens in a new tab) Benzinga · 10 Nov 2026 14:57
- Charles River agrees $470m deal for Frontage assets (opens in a new tab) Hospital Management · 10 Nov 2026 10:41
- Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses (opens in a new tab) Fintel · 09 Nov 2026 13:22
- Unlocking Charles River (CRL) International Revenues: Trends, Surprises, and Prospects (opens in a new tab) Zacks · 09 Nov 2026 13:15
- CRAI Q3 Earnings & Revenues Surpass Estimates, Stock Barely Moves (opens in a new tab) Zacks · 09 Nov 2026 12:27
- Dimensional U.S. Small Cap ETF (DFAS) Sells $24.2 Million of Charles River on Nov. 5 (opens in a new tab) GuruFocus.com · 09 Nov 2026 11:06
- Charles River Laboratories To Acquire Frontage Holdings Corporation’s Bioanalysis And DMPK Operations In Pennsylvania For ~$470M In Cash Plus Additional Payments Of Up To $75M (opens in a new tab) Benzinga · 09 Nov 2026 07:19
- Microbiology Contract Research Organization (CRO) Services - Global Strategic Business Report 2026: Capture the $11.3B Market; Benchmark Charles River, Eurofins, SGS and WuXi AppTec (opens in a new tab) 06 Nov 2026 15:30
- Charles River Laboratories International, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 10:47
- Charles River Laboratories International (CRL) Lifted Guidance, Is The Stock Already Pricey? (opens in a new tab) Simply Wall St. · 05 Nov 2026 22:09
- UBS Maintains Buy on Charles River, Raises Price Target to $387 (opens in a new tab) Benzinga · 05 Nov 2026 20:24
- Will Earnings Beat Change Charles River Laboratories' (CRL) Narrative (opens in a new tab) Simply Wall St. · 05 Nov 2026 17:09
- RBC Capital Maintains Outperform on Charles River, Raises Price Target to $352 (opens in a new tab) Benzinga · 05 Nov 2026 14:48
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 340.81 USD
- Market cap
- 16.3B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CRL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.